Peptide Technologies at Energypolis

Authors

  • Marc Mathieu HES-SO Valais-Wallis, Institute of Life Technologies, Campus Energypolis, Route de Rawyl 47, CH-1950 Sion, Switzerland
  • Origène Nyanguile HES-SO Valais-Wallis, Institute of Life Technologies, Campus Energypolis, Route de Rawyl 47, CH-1950 Sion, Switzerland;, Email: origene.nyanguile@hevs.ch

DOI:

https://doi.org/10.2533/chimia.2021.539

Keywords:

Biomaterials, Cyclic peptides, N0-p complex, Peptide–drug conjugates, Peptidomimetics, Regioselective labeling, Stapled peptides, Therapeutic antibodies

Abstract

The new Energypolis campus brings together the skills of EPFL Valais-Wallis, HES-SO Valais-Wallis, and the Ark Foundation's services. Together these partners respond to today's major concerns in the domains of energy, health, and the environment cutting-edge technology. The spirit of this new campus is to foster innovation in these disciplines and emulate the creation of start-up companies. The HES-SO hosts the School of Engineering (HEI) at this campus, which includes the following degree programmes: Life Technologies, Systems Engineering and Energy and Environmental Engineering, as well as their corresponding applied research institutes. Peptide technologies belong to the many activities that are carrying out in the Institute of Life Technologies. The present review summarizes the peptide technologies that are currently under development, that is, the regioselective labeling of therapeutic antibodies for cancer imaging, the development of peptide antivirals and antimicrobials for the treatment of infectious diseases, targeting of drugs conjugated to peptidic scaffolds as well as engineering of biomaterials.

Downloads

Published

2021-06-30

How to Cite

[1]
M. Mathieu, O. Nyanguile, Chimia 2021, 75, 539, DOI: 10.2533/chimia.2021.539.